Recommendations for ICT use in Alzheimer’s disease assessment: Monaco CTAD expert meeting

Alzheimer disease (AD) and other related dementia represent a major challenge for health care systems within the aging population. It is therefore important to develop better instruments for assessing disease severity and disease progression to optimize patient’s care and support to care providers,...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of nutrition, health & aging Vol. 17; no. 8; pp. 653 - 660
Main Authors Robert, Philippe H, Konig, A, Andrieu, S, Bremond, F, Chemin, I, Chung, P. C, Dartigues, J. F, Dubois, B, Feutren, G, Guillemaud, R, Kenisberg, P. A, Nave, S, Vellas, B, Verhey, F, Yesavage, J, Mallea, P
Format Journal Article Conference Proceeding
LanguageEnglish
Published Paris Springer-Verlag 2013
Springer Paris
Springer
Springer Nature B.V
Springer Verlag (Germany)
Subjects
Use
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer disease (AD) and other related dementia represent a major challenge for health care systems within the aging population. It is therefore important to develop better instruments for assessing disease severity and disease progression to optimize patient’s care and support to care providers, and also provide better tools for clinical research. In this area, Information and Communication Technologies (ICT) are of particular interest. Such techniques enable accurate and standardized assessments of patients’ performance and actions in real time and real life situations. The aim of this article is to provide basic recommendation concerning the development and the use of ICT for Alzheimer’s disease and related disorders. During he ICT and Mental Health workshop (CTAD meeting held in Monaco on the 30th October 2012) an expert panel was set up to prepare the first recommendations for the use of ICT in dementia research. The expert panel included geriatrician, epidemiologist, neurologist, psychiatrist, psychologist, ICT engineers, representatives from the industry and patient association. The recommendations are divided into three sections corresponding to 1/ the clinical targets of interest for the use of ICT, 2/ the conditions, the type of sensors and the outputs (scores) that could be used and obtained, 3/ finally the last section concerns specifically the use of ICT within clinical trials.
Bibliography:http://dx.doi.org/10.1007/s12603-013-0046-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 25
ObjectType-News-3
SourceType-Conference Papers & Proceedings-1
ObjectType-Conference-4
ISSN:1279-7707
1760-4788
DOI:10.1007/s12603-013-0046-3